Arrow-right Camera


Osteoporosis Drug A Milestone

The Food and Drug Administration Monday approved the first nonhormonal drug to treat osteoporosis, a progressive and often crippling bone disease that may afflict as many as 25 million Americans.

The approval offers the first drug alternative to hormone replacement therapy for post-menopausal women, who are particularly susceptible to the condition.

Hormones have been associated with an increased risk of cancer of the breast and uterus.


Click here to comment on this story »